Endocrinology · Water and Electrolyte Disorders
The facts most likely to be tested
SIADH presents with euvolemic hyponatremia characterized by low serum osmolality (<275 mOsm/kg) and inappropriately high urine osmolality (>100 mOsm/kg).
The pathophysiology involves excessive ADH secretion leading to free water retention and subsequent dilutional hyponatremia.
Patients with SIADH are clinically euvolemic, lacking signs of edema, ascites, or orthostatic hypotension.
Small cell lung cancer is the most common paraneoplastic syndrome associated with SIADH.
Common pharmacologic triggers for SIADH include SSRIs, carbamazepine, and cyclophosphamide.
First-line management for mild to moderate SIADH is fluid restriction to prevent further free water accumulation.
Severe symptomatic hyponatremia, such as seizures or coma, requires hypertonic saline (3%) to rapidly increase serum sodium levels.
Vignette unlocked
A 68-year-old male with a 30-pack-year smoking history presents to the clinic with a two-week history of confusion and lethargy. Physical examination reveals a moist mucous membrane and no peripheral edema, confirming a euvolemic state. Laboratory studies show a serum sodium of 122 mEq/L, serum osmolality of 250 mOsm/kg, and a urine osmolality of 450 mOsm/kg. A chest X-ray reveals a central lung mass.
What is the most appropriate initial management for this patient's electrolyte disturbance?
Fluid restriction
The patient exhibits classic signs of SIADH secondary to a suspected malignancy; since the patient is not experiencing severe neurological symptoms like seizures, the first-line treatment is fluid restriction.
Full handout
High yield triage
Etiology / Epidemiology
Common in small cell lung cancer, CNS disorders, and SSRIs. Characterized by euvolemic hyponatremia.
Clinical Manifestations
Often asymptomatic; severe cases present with seizures or coma due to cerebral edema.
Diagnosis
Diagnosis of exclusion: serum osmolality < 275 mOsm/kg and urine osmolality > 100 mOsm/kg.
Treatment
First-line is fluid restriction (< 800-1000 mL/day). Avoid rapid correction to prevent osmotic demyelination syndrome.
Prognosis
Prognosis depends on underlying cause; serum sodium must be monitored closely during correction.
Full handout
Epidemiology & Etiology
Most frequently associated with small cell lung cancer (ectopic ADH production). Other triggers include CNS trauma/infection, pulmonary disease (pneumonia), and medications like SSRIs or carbamazepine. It is the most common cause of hyponatremia in hospitalized patients.
Pertinent Anatomy
The posterior pituitary stores ADH, which acts on the collecting ducts of the kidney. Excessive ADH leads to unregulated aquaporin-2 channel insertion, causing massive free water reabsorption.
Pathophysiology
Excessive ADH secretion leads to water retention, expanding total body water while maintaining a euvolemic state. The body compensates via natriuresis (aldosterone suppression), which paradoxically worsens the hyponatremia. This results in a dilute serum and inappropriately concentrated urine.
Clinical Manifestations
Patients are typically euvolemic (no edema or JVD). Symptoms correlate with the rate of sodium decline: nausea and malaise progress to seizures, obtundation, and respiratory arrest. Rapid decline in sodium is a medical emergency requiring immediate intervention to prevent cerebral edema.
Diagnosis
Diagnosis requires serum osmolality < 275 mOsm/kg and urine osmolality > 100 mOsm/kg in the setting of euvolemia. Serum uric acid is typically low (< 4 mg/dL). Always rule out hypothyroidism and adrenal insufficiency before confirming.
Treatment
Initial management is fluid restriction. If severe or symptomatic, use hypertonic saline (3%) with extreme caution. Do not exceed 8 mEq/L/24h correction rate to prevent osmotic demyelination syndrome (formerly central pontine myelinolysis). Use demeclocycline or vaptans only in refractory chronic cases.
Prognosis
Outcome is tied to the underlying malignancy or trigger. Osmotic demyelination syndrome is the most feared complication of over-aggressive correction, leading to permanent neurological deficits or death.
Differential Diagnosis
Psychogenic polydipsia: urine osmolality < 100 mOsm/kg
Hypovolemic hyponatremia: clinical signs of dehydration present
CHF/Cirrhosis: hypervolemic state with edema/ascites
Adrenal insufficiency: hyperkalemia and hypotension present
Hypothyroidism: elevated TSH and clinical signs of myxedema